STXS
Strong SellSinkerStereotaxis, Inc. · Healthcare · United States · $145M · Avg Vol: $789K/d
Sinker: Weak, expensive and falling. Nothing here to keep it afloat.
5
StockRankGet insider-trade alerts
QualityQuality
30
ValueValue
25
MomentumMomentum
19
P/E (TTM)
—
peers 25.1x
ROE
-184.3%
peers -30.9%
D/E
0.3x
peers 0.2x
Dividend %
—
trailing yield
ABOUT STEREOTAXIS, INC.
Read
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 28.1M | 26.8M | 26.9M | 32.4M | 4.8% | 30.1M | 34.3M | 45.7M | 18.8% |
| EPS | -0.26 | -0.27 | -0.30 | -0.25 | — | -0.24 | -0.21 | -0.16 | — |
| Shares | 74.9M | 80.9M | 85.3M | 95.3M | +27.3% | 100.2M | — | — | — |
| Debt | 5.9M | 5.5M | 6.0M | 5.4M | -2.5% | 5.2M | — | — | — |
| Equity | 31.9M | 21.9M | 11.4M | 18.7M | -16.3% | — | — | — | — |
| Op CF | -8.4M | -9.1M | -8.5M | -13.7M | — | -15.3M | — | — | — |
| Inv CF | -22.1M | 19.8M | 74.0K | -93.0K | — | — | — | — | — |
| Fin CF | 0.2M | 81.0K | 0.3M | 14.8M | — | — | — | — | — |
Loading 1Y...
PRICE (1Y)-5.6%
SMA 50SMA 200
Close
$1.36
RSI (14)
39.5
52W High
$3.59
From 52W High
0.4%
SCORE BREAKDOWN
Quality
30
ROIC
-74.1%9.9
ROE
-184.3%4.7
GP/Assets
32.0%67.5
Op. Margin
-59.6%19.7
FCF/Assets
-26.4%16.1
Piotroski
549.1
Int. Cover
—N/A
D/E Ratio
0.30x41.4
Current Ratio
1.42x24.2
Value
25
P/E (TTM)
—N/A
EV/EBITDA
-7.4x25.0
P/FCF
—N/A
P/B
10.6x10.6
P/S
4.4x43.7
Div Yield
—N/A
Momentum
19
52W High %
38%11.6
RS 6M
-44%20.6
SMA 50/200
0.74x10.1
EPS Rev 4W
-22.4%3.0
EPS Rev 12W
—N/A
EPS Improve
+35%45.2
Q Growth
—N/A
FUNDAMENTALS
Market Cap
$145M
P/E (Forward)
-8.6x
Gross Margin
55.6%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of STXS are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| STXS | Stereotaxis, Inc.(you) | $145M | 5 | Strong Sell |
| KRMD | KORU Medical Systems, Inc. | $148M | 25 | Sell |
| OSUR | OraSure Technologies, Inc. | $248M | 33 | Sell |
| DXR | Daxor Corporation | $60M | 50 | Hold |
| KMTS | Kestra Medical Technologies, Ltd. | $1.5B | 26 | Sell |
| ANGO | AngioDynamics, Inc. | $655M | 52 | Hold |
| SMTI | Sanara MedTech Inc. | $318M | 68 | Buy |
| PLSE | Pulse Biosciences, Inc. | $3.4B | 22 | Sell |
| AZTA | Azenta, Inc. | $1.4B | 46 | Hold |
| WRBY | Warby Parker Inc. | $3.1B | 34 | Sell |
Peer medians: ROE -30.9% · P/E 25.1x · Gross margin 58.3%
Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.